Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Head and Neck Cancer

  Free Subscription


28.01.2019

3 Ann Surg
3 BMC Cancer
3 Br J Cancer
1 Br J Oral Maxillofac Surg
1 Cancer
1 Clin Cancer Res
2 Clin Nucl Med
2 Dis Esophagus
1 Gastrointest Endosc
12 Head Neck
3 Histopathology
4 Int J Cancer
3 Int J Radiat Oncol Biol Phys
1 J Laryngol Otol
2 Laryngoscope
2 Otolaryngol Head Neck Surg
3 PLoS One
3 Surgery


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. SUN HB, Li Y, Liu XB, Zhang RX, et al
    Early Oral Feeding Following McKeown Minimally Invasive Esophagectomy: An Open-label, Randomized, Controlled, Noninferiority Trial.
    Ann Surg. 2018;267:435-442.
    PubMed     Text format     Abstract available

  2. WORRELL SG, Alicuben ET, Oh DS, Hagen JA, et al
    Accuracy of Clinical Staging and Outcome With Primary Resection for Local-Regionally Limited Esophageal Adenocarcinoma.
    Ann Surg. 2018;267:484-488.
    PubMed     Text format     Abstract available

  3. BABA Y, Yoshida N, Kinoshita K, Iwatsuki M, et al
    Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution Study.
    Ann Surg. 2018;267:478-483.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. SUN XS, Liu LT, Liu SL, Guo SS, et al
    Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
    BMC Cancer. 2019;19:92.
    PubMed     Text format     Abstract available

  5. KIM SY, Kim SM, Chang HJ, Kim BW, et al
    SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer.
    BMC Cancer. 2018;18:956.
    PubMed     Text format     Abstract available

  6. SIKORSKA J, Gawel D, Domek H, Rudzinska M, et al
    Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
    BMC Cancer. 2019;19:85.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. FLEMING JC, Woo J, Moutasim K, Mellone M, et al
    HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Jan 17. pii: 10.1038/s41416-018-0364.
    PubMed     Text format     Abstract available

  8. ALMANGUSH A, Heikkinen I, Makitie AA, Coletta RD, et al
    Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis".
    Br J Cancer. 2018;118:e12.
    PubMed     Text format    

  9. JAYARAJ R, Kumarasamy C
    Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis'.
    Br J Cancer. 2018;118:e11.
    PubMed     Text format    


    Br J Oral Maxillofac Surg

  10. LANGTON S, Rijken JA, Bankhead CR, Pluddemann A, et al
    Referrals for head and neck cancer in England and The Netherlands: an international qualitative study of the views of secondary-care surgical specialists.
    Br J Oral Maxillofac Surg. 2019 Jan 17. pii: S0266-4356(19)30002.
    PubMed     Text format     Abstract available


    Cancer

  11. MONDACA S, Janjigian YY
    Application of positron emission tomography imaging to personalize esophagogastric cancer care.
    Cancer. 2019 Jan 22. doi: 10.1002/cncr.31940.
    PubMed     Text format    


    Clin Cancer Res

  12. DIGOMANN D, Kurth I, Tyutyunnykova A, Chen O, et al
    The CD98 heavy chain is a marker and regulator of head and neck squamous cell carcinoma radiosensitivity.
    Clin Cancer Res. 2019 Jan 22. pii: 1078-0432.CCR-18-2951.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  13. MORENO AJ, Wang B
    18F-FDG PET/CT of Squamous Cell Carcinoma in a Thyroglossal Duct Cyst.
    Clin Nucl Med. 2018 Oct 27. doi: 10.1097/RLU.0000000000002351.
    PubMed     Text format     Abstract available

  14. NEMER JS, Hsieh MP, Chen D, O'Toole KM, et al
    Poorly Differentiated Primary Carcinoma of the Middle Ear on 18F-FDG PET/CT.
    Clin Nucl Med. 2018 Oct 27. doi: 10.1097/RLU.0000000000002361.
    PubMed     Text format     Abstract available


    Dis Esophagus

  15. ENG OS, Nelson RA, Konstantinidis I, Chao J, et al
    Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available

  16. YOSHIDA N, Baba Y, Kuroda D, Miyamoto Y, et al
    Clinical utility of exhaled carbon monoxide in assessing preoperative smoking status and risks of postoperative morbidity after esophagectomy.
    Dis Esophagus. 2018;31.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  17. YANG F, Ma D, Li Z
    Screening for esophageal squamous cell carcinoma: insight from experience with Barrett's esophagus.
    Gastrointest Endosc. 2019;89:443-444.
    PubMed     Text format    


    Head Neck

  18. MEHTA V, Ow TJ, Kim S, Tharakan T, et al
    Significant racial differences in the incidence and behavior of the follicular variant of papillary thyroid carcinoma.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25596.
    PubMed     Text format     Abstract available

  19. BUGTER O, van Iwaarden DLP, Dronkers EAC, de Herdt MJ, et al
    Survival of patients with head and neck cancer with metachronous multiple primary tumors is surprisingly favorable.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25595.
    PubMed     Text format     Abstract available

  20. SU WW, Su CW, Chang DC, Chuang SL, et al
    Impact of varying anatomic sites on advanced stage and survival of oral cancer: A 9-year prospective cohort of 27 717 cases.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25579.
    PubMed     Text format     Abstract available

  21. CABEZAS-CAMARERO S, Garcia-Barberan V, Saiz-Pardo Sanz M, Cabrera-Martin MN, et al
    Durable intracranial and extracranial response to nivolumab with appearance of secondary resistance in a heavily pretreated patient with head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25635.
    PubMed     Text format     Abstract available

  22. PAVON MA, Arroyo-Solera I, Leon X, Tellez-Gabriel M, et al
    The combined use of EFS, GPX2, and SPRR1A expression could distinguish favorable from poor clinical outcome among epithelial-like head and neck carcinoma subtypes.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25623.
    PubMed     Text format     Abstract available

  23. FAGAN JJ, Otiti J, Aswani J, Konney A, et al
    African head and neck fellowships: A model for a sustainable impact on head and neck cancer care in developing countries.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25615.
    PubMed     Text format     Abstract available

  24. BUTTERWORTH CJ
    Primary vs secondary zygomatic implant placement in patients with head and neck cancer-A 10-year prospective study.
    Head Neck. 2019 Jan 21. doi: 10.1002/hed.25645.
    PubMed     Text format     Abstract available

  25. KLIGERMAN MP, Sethi RKV, Kozin ED, Gray ST, et al
    Morbidity and mortality among patients with head and neck cancer in the emergency department: A national perspective.
    Head Neck. 2019 Jan 24. doi: 10.1002/hed.25534.
    PubMed     Text format     Abstract available

  26. SOOD A, Wykes J, Roshan D, Wang LY, et al
    A critical analysis of the prognostic performance of the 8th edition American Joint Committee on Cancer staging for metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 19. doi: 10.1002/hed.25599.
    PubMed     Text format     Abstract available

  27. HUANG HI, Chen CH, Wang SH, Wang LH, et al
    Effects of APE1 Asp148Glu polymorphisms on OPMD malignant transformation, and on susceptibility to and overall survival of oral cancer in Taiwan.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25576.
    PubMed     Text format     Abstract available

  28. MIRABILE A, Miceli R, Calderone RG, Locati L, et al
    Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25636.
    PubMed     Text format     Abstract available

  29. KRAAIJENGA SA, Hamming-Vrieze O, Verheijen S, Lamers E, et al
    Radiation dose to the masseter and medial pterygoid muscle in relation to trismus after chemoradiotherapy for advanced head and neck cancer.
    Head Neck. 2019 Jan 16. doi: 10.1002/hed.25573.
    PubMed     Text format     Abstract available


    Histopathology

  30. SOARES CD, Morais TML, Carlos R, Jorge J, et al
    Sebaceous adenocarcinomas of the major salivary glands: a clinicopathological analysis of 10 cases.
    Histopathology. 2018;73:585-592.
    PubMed     Text format     Abstract available

  31. SCHNEIDER S, Kadletz L, Wiebringhaus R, Kenner L, et al
    PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Histopathology. 2018;73:573-584.
    PubMed     Text format     Abstract available

  32. BOXBERG M, Gotz C, Haidari S, Dorfner C, et al
    Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
    Histopathology. 2018;73:559-572.
    PubMed     Text format     Abstract available


    Int J Cancer

  33. BOON E, Bel M, van Boxtel W, van der Graaf WTA, et al
    A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
    Int J Cancer. 2018;143:758-766.
    PubMed     Text format     Abstract available

  34. MC MENAMIN UC, Kunzmann AT, Cook MB, Johnston BT, et al
    Hormonal and reproductive factors and risk of upper gastrointestinal cancers in men: A prospective cohort study within the UK Biobank.
    Int J Cancer. 2018;143:831-841.
    PubMed     Text format     Abstract available

  35. BAO C, Pedersen NL, Yang R, Marseglia A, et al
    Diabetes in midlife and risk of cancer in late life: A nationwide Swedish twin study.
    Int J Cancer. 2018;143:793-800.
    PubMed     Text format     Abstract available

  36. ZHANG Y, Yuan Y, Wu H, Xie Z, et al
    Effect of verbascoside on apoptosis and metastasis in human oral squamous cell carcinoma.
    Int J Cancer. 2018;143:980-991.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  37. DAISNE JF, Nuyts S, Duprez F, Bihin B, et al
    In Regard to Bibault et al.
    Int J Radiat Oncol Biol Phys. 2018;100:807-808.
    PubMed     Text format    

  38. OVERGAARD J
    In Regards to Stokes et al and Bledsoe et al.
    Int J Radiat Oncol Biol Phys. 2018;100:804-805.
    PubMed     Text format    

  39. WU L, Chung YL
    Tumor-infiltrating T-cell Receptor-beta Repertoires are Linked to the Risk of Late Chemoradiation-induced Temporal Lobe Necrosis in Locally Advanced Nasopharyngeal Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019 Jan 14. pii: S0360-3016(19)30037.
    PubMed     Text format     Abstract available


    J Laryngol Otol

  40. ELWANY S, Radi S, Khalil H, Talaat I, et al
    Cluster of differentiation 8 T-cell population in the laryngeal mucosa of smokers with laryngeal cancer.
    J Laryngol Otol. 2018;132:1134-1137.
    PubMed     Text format     Abstract available


    Laryngoscope

  41. PETERSEN JF, Berlanga A, Stuiver MM, Hamming-Vrieze O, et al
    Improving decision making in larynx cancer by developing a decision aid: A mixed methods approach.
    Laryngoscope. 2019 Jan 21. doi: 10.1002/lary.27800.
    PubMed     Text format     Abstract available

  42. XIAO R, Sethi RKV, Feng AL, Fontanarosa JB, et al
    The Role of Elective Neck Dissection in Patients With Adenoid Cystic Carcinoma of the Head and Neck.
    Laryngoscope. 2019 Jan 22. doi: 10.1002/lary.27814.
    PubMed     Text format     Abstract available


    Otolaryngol Head Neck Surg

  43. TALMADGE J, Judge P, Sayed Z
    When Have We Done Enough? Provider-Patient Discord in Terminal Head and Neck Cancer.
    Otolaryngol Head Neck Surg. 2019 Jan 22:194599818825457.
    PubMed     Text format    

  44. GANE EM, McPhail SM, Hatton AL, Panizza BJ, et al
    Neck and Shoulder Motor Function following Neck Dissection: A Comparison with Healthy Control Subjects.
    Otolaryngol Head Neck Surg. 2019 Jan 22:194599818821885.
    PubMed     Text format     Abstract available


    PLoS One

  45. SEONG CY, Chai YJ, Lee SM, Kim SJ, et al
    Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
    PLoS One. 2018;13:e0200166.
    PubMed     Text format     Abstract available

  46. YANG SH, Lee TY, Ho CA, Yang CY, et al
    Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0201267.
    PubMed     Text format     Abstract available

  47. SHIMAMURA M, Shibusawa N, Kurashige T, Mussazhanova Z, et al
    Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels.
    PLoS One. 2018;13:e0201365.
    PubMed     Text format     Abstract available


    Surgery

  48. FRANKO J, McAvoy S
    Timing of esophagectomy after neoadjuvant chemoradiation treatment in squamous cell carcinoma.
    Surgery. 2018;164:455-459.
    PubMed     Text format     Abstract available


  49. Discussion.
    Surgery. 2018;164:793-794.
    PubMed     Text format    

  50. CHENG SP, Chien MN, Wang TY, Lee JJ, et al
    Reconsideration of tumor size threshold for total thyroidectomy in differentiated thyroid cancer.
    Surgery. 2018 May 26. pii: S0039-6060(18)30188.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: